Literature DB >> 14576543

Using front-end kinetics to optimize target-controlled drug infusions.

Michael J Avram1, Tom C Krejcie.   

Abstract

BACKGROUND: The mode of drug administration, blood sampling schedule, and sampling site affect the pharmacokinetic model derived. The present study tested the hypothesis that three-compartment pharmacokinetic model parameters derived from arterial drug concentrations obtained after rapid intravenous administration can be used to design a target-controlled drug infusion (TCI) that deviates minimally from the target.
METHODS: Arterial thiopental concentration data obtained from the moment of injection in a previous study of five dogs were used. Three three-compartment models were constructed, one based on early concentrations classically obtained at 1, 2, and 3 min; another using all concentrations obtained beginning with the thiopental recirculation peak; and the last with the initial distribution volume (VC) fixed to the sum of VC and the nondistributive volume of the recirculatory model from the earlier study. Using these models, TCIs were designed that would maintain 20 mug/ml thiopental concentrations in VC for 60 min if simulated with the models used in their design. Drug concentrations resulting from these TCIs were then simulated using recirculatory model kinetics, and prediction errors were evaluated.
RESULTS: Models with VCs estimated from intermittent or frequent early blood concentrations overestimated not only VC but also the volume and clearance of the rapidly equilibrating tissues, and their TCIs significantly overshot the target. With VC fixed to recirculatory model parameters, drug distribution was described in a manner consistent with that of the recirculatory model, and the TCI deviated minimally from the target. A similar three-compartment model was derived from data obtained from a simulation of a 2-min infusion using recirculatory kinetic parameters.
CONCLUSIONS: Because three-compartment models based on drug concentration histories obtained after rapid intravenous administration do not characterize VC accurately, TCIs based on them produce concentrations exceeding the target. A model capable of producing TCIs deviating minimally from the target can be derived from data obtained during and after a brief drug infusion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14576543     DOI: 10.1097/00000542-200311000-00013

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  11 in total

1.  Induction speed is not a determinant of propofol pharmacodynamics.

Authors:  Anthony G Doufas; Maryam Bakhshandeh; Andrew R Bjorksten; Steven L Shafer; Daniel I Sessler
Journal:  Anesthesiology       Date:  2004-11       Impact factor: 7.892

Review 2.  [Target-controlled infusion. Clinical relevance and special features when using pharmacokinetic models].

Authors:  H Ihmsen; S Schraag; S Kreuer; J Bruhn; S Albrecht
Journal:  Anaesthesist       Date:  2009-07       Impact factor: 1.041

3.  Comparison of distributed and compartmental models of drug disposition: assessment of tissue uptake kinetics.

Authors:  Michael Weiss
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-08-17       Impact factor: 2.745

4.  Cyclosporine-inhibitable blood-brain barrier drug transport influences clinical morphine pharmacodynamics.

Authors:  Konrad Meissner; Michael J Avram; Viktar Yermolenka; Amber M Francis; Jane Blood; Evan D Kharasch
Journal:  Anesthesiology       Date:  2013-10       Impact factor: 7.892

Review 5.  General Purpose Pharmacokinetic-Pharmacodynamic Models for Target-Controlled Infusion of Anaesthetic Drugs: A Narrative Review.

Authors:  Ophélie Vandemoortele; Laura N Hannivoort; Florian Vanhoorebeeck; Michel M R F Struys; Hugo E M Vereecke
Journal:  J Clin Med       Date:  2022-04-28       Impact factor: 4.964

6.  Anesthetic Pharmacology and the Morbidly Obese Patient.

Authors:  Jerry Ingrande; Hendrikus Jm Lemmens
Journal:  Curr Anesthesiol Rep       Date:  2012-12-13

7.  Assessing the utility of the utility function.

Authors:  Evan D Kharasch; Carl E Rosow
Journal:  Anesthesiology       Date:  2013-09       Impact factor: 7.892

8.  How does obesity affect residence time dispersion and the shape of drug disposition curves? Thiopental as an example.

Authors:  Michael Weiss
Journal:  J Pharmacokinet Pharmacodyn       Date:  2008-05-09       Impact factor: 2.745

9.  An evaluation of remifentanil propofol response surfaces for loss of responsiveness, loss of response to surrogates of painful stimuli and laryngoscopy in patients undergoing elective surgery.

Authors:  Ken B Johnson; Noah D Syroid; Dhanesh K Gupta; Sandeep C Manyam; Talmage D Egan; Jeremy Huntington; Julia L White; Diane Tyler; Dwayne R Westenskow
Journal:  Anesth Analg       Date:  2008-02       Impact factor: 5.108

10.  Obesity and anesthetic pharmacology: simulation of target-controlled infusion models of propofol and remifentanil.

Authors:  Tae Kyun Kim
Journal:  Korean J Anesthesiol       Date:  2021-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.